Stockreport

Rapport Therapeutics Announces Pricing of Initial Public Offering

Rapport Therapeutics, Inc.  (RAPP) 
PDF BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and deve [Read more]